NASDAQ:EKSO

Ekso Bionics - EKSO Stock Forecast, Price & News

$1.70

0.00 (0.00%)

(As of 02/3/2023 12:00 AM ET)

Add

Compare

Today's Range: $1.70
▼
$1.77
50-Day Range: $1.04
▼
$1.88
52-Week Range: $1.03
▼
$3.15

Volume: 30,066 shs
Average Volume: 53,570 shs
Market Capitalization: $22.34 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $9.00

Institutional Ownership

Ekso Bionics MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 429.4% Upside
$9.00 Price Target
Short Interest: Healthy
0.61% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.46
Based on 10 Articles This Week
Insider Trading: Selling Shares
$15,464 Sold Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.95 out of 5 stars

Medical Sector

545th out of 1,028 stocks

General Industrial Machinery, Industry

4th out of 10 stocks

3.5

Analyst's Opinion

Consensus Rating
Ekso Bionics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $9.00, Ekso Bionics has a forecasted upside of 429.4% from its current price of $1.70.
Amount of Analyst Coverage
Ekso Bionics has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.61% of the float of Ekso Bionics has been sold short.
Short Interest Ratio / Days to Cover
Ekso Bionics has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Ekso Bionics has recently increased by 36.38%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Ekso Bionics does not currently pay a dividend.
Dividend Growth
Ekso Bionics does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for EKSO.

1.9

News and Social Media Coverage

News Sentiment
Ekso Bionics has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Ekso Bionics this week, compared to 1 article on an average week.
Search Interest
Only 1 people have searched for EKSO on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
Only 3 people have added Ekso Bionics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Ekso Bionics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,464.00 in company stock.
Percentage Held by Insiders
Only 3.05% of the stock of Ekso Bionics is held by insiders.
Percentage Held by Institutions
Only 12.74% of the stock of Ekso Bionics is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Ekso Bionics is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Ekso Bionics is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Ekso Bionics has a P/B Ratio of 0.58. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Ekso Bionics (NASDAQ:EKSO) Stock

Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following segments: EksoHealth and EksoWorks. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Receive EKSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter.

EKSO Stock News Headlines

February 5, 2023 | marketwatch.com

With Astonishing CAGR, Medical Exoskeleton Robots Market Generate Revenue at Significant Rate, 2029

February 4, 2023 | marketwatch.com

Medical Robotics Market (New Report) to Witness A Pronounce Growth During 2023-2029

February 5, 2023 | Wall Street Watch Dogs (Ad)

A gold storm is coming…

“We are in the early stages of a mania – the calm before the storm.”...

February 3, 2023 | marketwatch.com

With Astonishing CAGR, Passive Exoskeleton Market Generate Revenue at Significant Rate, 2029

February 2, 2023 | marketwatch.com

Telemedicine Robots Market to Grow Significantly by Leading Players 2023 to 2028

February 2, 2023 | americanbankingnews.com

StockNews.com Initiates Coverage on Ekso Bionics (NASDAQ:EKSO)

January 31, 2023 | marketwatch.com

Exoskeleton Market 2023 Trend and Forecast Analysis by 2029 - Cyberdyne, Hocoma, ReWalk Robotics, Ekso Bionics

January 30, 2023 | marketwatch.com

Artificial Organs Market 2023 Company Challenges, Latest Advancements, Growth Prediction, and Forecast by 2028

February 5, 2023 | Tradewins (Ad)

Know Your Profit Potential BEFORE You Trade!

I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now!

January 30, 2023 | benzinga.com

Rehabilitation Equipment Market Size to Reach USD 23.73 Billion in 2030 | Emergen Research

January 30, 2023 | marketwatch.com

Rehabilitation Robotics Market Trends 2023-2029 by Key Players - AlterG, Bionik, Ekso Bionics, Myomo

January 30, 2023 | marketwatch.com

Powered Exoskeleton Market High Growth Opportunities 2023 | CAGR Status, Industry Changing Dynamics, and Size Forecast to 2027

January 28, 2023 | americanbankingnews.com

Short Interest in Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Expands By 36.4%

January 26, 2023 | marketwatch.com

Forecast 2028 for the Telemedicine Robots Market in terms of Size, Profits, Gross Margin, and Market share

January 26, 2023 | americanbankingnews.com

Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com

January 26, 2023 | marketwatch.com

Wearable Robotic Exoskeleton Market 2023 : Opportunities in Future, Business Growth Analysis by Top Countries Data and Industry Players by 2028

January 24, 2023 | marketwatch.com

Balance Rehabilitation Machine Market : A Comprehensive Analysis of the Global Industry from 2023 to 2029, Including Size, Share, Growth, and Trends

January 23, 2023 | msn.com

FDA clears Wandercraft's exoskeleton for stroke patient rehab

January 19, 2023 | marketwatch.com

Bionic Exoskeletons Market: 2023 [Latest Report] By Top Leading Players Analysis Till 2028

January 18, 2023 | marketwatch.com

Socially Assistive Healthcare Assistive Robot Market : Share, Industry Size, Opportunities, Analysis and Forecast to 2028 with Top Countries Data

January 18, 2023 | marketwatch.com

Humanoid Healthcare Assistive Robot Market Share 2023 Comprehensive Insights, Innovations and Business Outlook till 2028

January 15, 2023 | marketwatch.com

Robotic Exoskeletons Market Size 2023 with strong supplier, Key factors, driving the market growth, Information 2028

January 13, 2023 | marketwatch.com

Bionic Exoskeletons Market Size, Share 2023 : Industry Growing Rapidly with Recent Trends, Development, Revenue by 2028

January 12, 2023 | marketwatch.com

Global Smart Upper Limb Exoskeleton Market Size 2023 Research Report by Market Dynamics, Drivers, Opportunities, SWOT Analysis and Forecast to 2028

January 12, 2023 | marketwatch.com

Human Augmentation Market Size, Status, Global outlook 2023 To 2029

January 12, 2023 | marketwatch.com

Exoskeleton Robots Market Set For Rapid Growth and Competitive Landscape: Cyberdyne, Hocoma, ReWalk Robotics, Ekso Bionics

January 9, 2023 | marketwatch.com

Rehabilitation Robotics Market Segmentation, Future Trends, Growth Overview, Key Companies and Forecast by 2028

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive EKSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter.

EKSO Company Calendar

Last Earnings: 11/01/2021
Today: 2/05/2023
Next Earnings (Estimated): 2/23/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: General industrial machinery,
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:EKSO
Previous Symbol: OTCMKTS:EKSOD
CUSIP: N/A
CIK: 1549084
Web: www.eksobionics.com
Phone: (510) 984-1761
Fax: 510-927-2647
Employees: 55
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $9.00
High Stock Price Forecast: $9.00
Low Stock Price Forecast: $9.00
Forecasted Upside/Downside: +429.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.15)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-9,760,000.00
Net Margins: -109.88%
Pretax Margin: -109.88%
Return on Equity: -45.07%
Return on Assets: -34.09%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.68
Quick Ratio: 4.23

Sales & Book Value

Annual Sales: $11.25 million
Price / Sales: 1.99
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.94 per share
Price / Book: 0.58

Miscellaneous

Outstanding Shares: 13,140,000
Free Float: 12,741,000
Market Cap: $22.34 million
Optionable: Not Optionable
Beta: 1.70

Key Executives

Scott Davis
Chief Executive Officer & Director

Jerome Wong
Chief Financial Officer, Secretary & Controller

Charlie Wu
Senior Director-Operations

Stephan Aderhold
Vice President-EMEA Sales & Marketing

Jason Jones
Vice President-Product Development

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

EKSO Stock - Frequently Asked Questions

Should I buy or sell Ekso Bionics stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ekso Bionics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EKSO shares.
View EKSO analyst ratings or view top-rated stocks.
What is Ekso Bionics' stock price forecast for 2023?: 1 equities research analysts have issued 12-month price objectives for Ekso Bionics' shares. Their EKSO share price forecasts range from $9.00 to $9.00. On average, they expect the company's stock price to reach $9.00 in the next twelve months. This suggests a possible upside of 429.4% from the stock's current price.
View analysts price targets for EKSO or view top-rated stocks among Wall Street analysts.
How have EKSO shares performed in 2023?: Ekso Bionics' stock was trading at $1.19 on January 1st, 2023. Since then, EKSO stock has increased by 42.9% and is now trading at $1.70.
View the best growth stocks for 2023 here.
Are investors shorting Ekso Bionics?: Ekso Bionics saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 68,600 shares, an increase of 36.4% from the December 31st total of 50,300 shares. Based on an average daily volume of 52,800 shares, the short-interest ratio is currently 1.3 days. Currently, 0.6% of the company's shares are sold short.
View Ekso Bionics' Short Interest.
When is Ekso Bionics' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our EKSO earnings forecast.
How were Ekso Bionics' earnings last quarter?: Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) posted its earnings results on Monday, November, 1st. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.25) by $0.10. The company earned $3.05 million during the quarter, compared to analysts' expectations of $2.58 million. Ekso Bionics had a negative net margin of 109.88% and a negative trailing twelve-month return on equity of 45.07%. During the same period last year, the business posted ($0.52) EPS.

When did Ekso Bionics' stock split?: Ekso Bionics's stock reverse split on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 4th 2016. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.
What other stocks do shareholders of Ekso Bionics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Ekso Bionics investors own include Organigram (OGI), Gran Tierra Energy (GTE), KushCo (KSHB), CNBX Pharmaceuticals (CNBX), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), Bionano Genomics (BNGO), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI) and ADMA Biologics (ADMA).
What is Ekso Bionics' stock symbol?: Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."
Who are Ekso Bionics' major shareholders?: Ekso Bionics' stock is owned by many different institutional and retail investors. Top institutional investors include Essex Investment Management Co. LLC (3.38%), Legato Capital Management LLC (0.29%), Strategic Wealth Investment Group LLC (0.22%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Jason C Jones, Jerome Wong, John Glenn, Scott G Davis and Steven Sherman.
View institutional ownership trends.
How do I buy shares of Ekso Bionics?: Shares of EKSO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Ekso Bionics' stock price today?: One share of EKSO stock can currently be purchased for approximately $1.70.
How much money does Ekso Bionics make?: Ekso Bionics (NASDAQ:EKSO) has a market capitalization of $22.34 million and generates $11.25 million in revenue each year. The company earns $-9,760,000.00 in net income (profit) each year or ($1.15) on an earnings per share basis.
How can I contact Ekso Bionics?: Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The official website for the company is www.eksobionics.com. The company can be reached via phone at (510) 984-1761, via email at investors@eksobionics.com, or via fax at 510-927-2647.

This page (NASDAQ:EKSO) was last updated on 2/5/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Ekso Bionics - EKSO Stock Forecast, Price & News

Ekso Bionics MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Ekso Bionics (NASDAQ:EKSO) Stock

EKSO Stock News Headlines

EKSO Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

EKSO Stock - Frequently Asked Questions

Overall MarketRank^™